We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$42.4B
1-Year Est. Return
181.11%
This Fund
S&P 500
This Quarter
Est. Return
-16.7%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$17B
AUM Growth
-$5.13B
(-23%)
Cap. Flow
-$794M
Cap. Flow
% of AUM
-4.67%
Top 10 Holdings %
Top 10 Hldgs %
43.02%
Holding
494
New
36
Increased
156
Reduced
156
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$108M |
| 2 |
Visa
V
|
+$102M |
| 3 |
Mercado Libre
MELI
|
+$73M |
| 4 |
Enphase Energy
ENPH
|
+$58.6M |
| 5 |
Snowflake
SNOW
|
+$57.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$147M |
| 2 |
Y
Alleghany Corp
Y
|
+$137M |
| 3 |
Applied Materials
AMAT
|
+$116M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$115M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.66% |
| 2 | Industrials | 25.1% |
| 3 | Healthcare | 17.44% |
| 4 | Financials | 14.96% |
| 5 | Communication Services | 5.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Airbnb
ABNB
$101B
| $51.2M | 0.3% |
575,315
-185,636
| -24% | -$24.2M |
|
|
ITCI
77
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $50.7M | 0.3% |
888,537
+367,094
| +70% | +$20.8M |
|
78
AptarGroup
ATR
$7.94B
| $49M | 0.29% |
474,723
+3,519
| +0.7% | +$384K |
|
79
Option Care Health
OPCH
$3.52B
| $48.4M | 0.28% |
1,740,520
-6,500
| -0.4% | -$185K |
|
80
Exelixis
EXEL
$13.9B
| $48.1M | 0.28% |
2,309,299
-51,148
| -2% | -$1.05M |
|
81
Roblox
RBLX
$36.6B
| $46.3M | 0.27% |
1,408,906
+93,660
| +7% | +$3.15M |
|
|
PRA
82
DELISTED
ProAssurance
PRA
| $46.1M | 0.27% |
1,950,000
+750,000
| +63% | +$17.6M |
|
83
Ryan Specialty Holdings
RYAN
$4.65B
| $45.1M | 0.26% |
1,150,000
+526,000
| +84% | +$19.9M |
|
|
YMAB
84
DELISTED
Y-mAbs Therapeutics
YMAB
| $44.7M | 0.26% |
2,952,671
+75,000
| +3% | +$875K |
|
85
AbbVie
ABBV
$454B
| $43.3M | 0.25% |
282,792
+236,416
| +510% | +$36.1M |
|
|
RVNC
86
DELISTED
Revance Therapeutics, Inc.
RVNC
| $43.1M | 0.25% |
3,117,052
+660,555
| +27% | +$10.2M |
|
87
Cooper Companies
COO
$10.3B
| $42.4M | 0.25% |
541,268
-148,748
| -22% | -$13.2M |
|
88
Trupanion
TRUP
$1.09B
| $42.2M | 0.25% |
700,000
+450,000
| +180% | +$30.6M |
|
89
LivaNova
LIVN
$4.44B
| $42.1M | 0.25% |
673,704
-13,691
| -2% | -$969K |
|
90
Snap
SNAP
$9.88B
| $41.6M | 0.24% |
3,165,191
-3,949,623
| -56% | -$90.1M |
|
|
ZEN
91
DELISTED
ZENDESK INC
ZEN
| $41.2M | 0.24% |
555,661
-677,288
| -55% | -$66.8M |
|
92
T-Mobile US
TMUS
$196B
| $40.6M | 0.24% |
301,824
+8,453
| +3% | +$1.1M |
|
93
Harmony Biosciences
HRMY
$2.42B
| $40.5M | 0.24% |
831,325
+281,325
| +51% | +$12.7M |
|
|
AXNX
94
DELISTED
Axonics, Inc. Common Stock
AXNX
| $40.3M | 0.24% |
710,336
| – | – |
|
95
Globus Medical
GMED
$9.96B
| $40M | 0.24% |
713,348
-14,570
| -2% | -$958K |
|
|
SMAR
96
DELISTED
Smartsheet Inc.
SMAR
| $39.5M | 0.23% |
1,256,595
-11,868
| -0.9% | -$492K |
|
97
Kornit Digital
KRNT
$690M
| $36.8M | 0.22% |
1,161,567
+428,169
| +58% | +$22.7M |
|
98
Sanofi
SNY
$104B
| $36.3M | 0.21% |
+725,000
| New | +$38.5M |
|
99
AngioDynamics
ANGO
$631M
| $36.2M | 0.21% |
1,872,236
-10,139
| -0.5% | -$208K |
|
100
Seagate
STX
$183B
| $35.7M | 0.21% |
500,293
-591,752
| -54% | -$48.1M |
|
Similar funds
GAM
SAM
Polar Capital Holdings's Q2 2022 Portfolio in Review
As of Q2 2022, Polar Capital Holdings held 494 positions worth $17B, down 23% from $22.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Polar Capital Holdings withdrew a net $794M in Q2 2022, closing 61 positions and reducing 156 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $147M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Polar Capital Holdings opened a new position in Sanofi worth $36.3M.
- Polar Capital Holdings's largest Q2 2022 buy was Sanofi: 725,000 shares worth $36.3M.
- Polar Capital Holdings added most to Salesforce in Q2 2022, an estimated $108M increase.
- Polar Capital Holdings's biggest Q2 2022 reduction was Applied Materials, cutting an estimated $116M.
- Polar Capital Holdings fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, selling an estimated $147M.
- Polar Capital Holdings's ten largest holdings make up 43% of its $17B portfolio in Q2 2022.
- Polar Capital Holdings opened 36 new positions and closed 61 in Q2 2022.
- Polar Capital Holdings's portfolio value fell 23% quarter-over-quarter to $17B.
Based on Polar Capital Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.